Related references
Note: Only part of the references are listed.UNOS Down-Staging Criteria for Liver Transplantation of Hepatocellular Carcinoma: Systematic Review and Meta-Analysis of 25 Studies
Darren Jun Hao Tan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)
FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far?
Iason Psilopatis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)
Bridging and downstaging with TACE in early and intermediate stage hepatocellular carcinoma: Predictors of receiving a liver transplant
Chao Yin et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2023)
Liver transplantation after successful downstaging of a locally advanced hepatocellular carcinoma with systemic therapy
Andreas Schmiderer et al.
DIGESTIVE DISEASES (2023)
Liver transplantation for hepatocellular carcinoma following checkpoint inhibitor therapy with nivolumab
Gabriel T. Schnickel et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2022)
Immunotherapies for hepatocellular carcinoma
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2022)
External Beam Radiation Therapy for Primary Liver Cancers: An ASTRO Clinical Practice Guideline
Smith Apisarnthanarax et al.
PRACTICAL RADIATION ONCOLOGY (2022)
OPTN/SRTR 2020 Annual Data Report: Liver
A. J. Kwong et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2022)
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
Maria Reig et al.
JOURNAL OF HEPATOLOGY (2022)
90Y Radioembolization versus Drug-eluting Bead Chemoembolization for Unresectable Hepatocellular Carcinoma: Results from the TRACE Phase II Randomized Controlled Trial
Elisabeth Dhondt et al.
RADIOLOGY (2022)
Immune Checkpoint Inhibitors as Therapy to Down-Stage Hepatocellular Carcinoma Prior to Liver Transplantation
Nitin N. Katariya et al.
CANCERS (2022)
Hepatocellular carcinoma downstaging for liver transplantation in the era of systemic combined therapy with anti-VEGF/TKI and immunotherapy
Nguyen H. Tran et al.
HEPATOLOGY (2022)
Patient Selection for Downstaging of Hepatocellular Carcinoma Prior to Liver Transplantation-Adjusting the Odds?
Daniel Seehofer et al.
TRANSPLANT INTERNATIONAL (2022)
PD-1 inhibitor as bridge therapy to liver transplantation?
Parissa Tabrizian et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2021)
Systemic treatment of hepatocellular carcinoma: An EASL position paper
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2021)
Evolution of Radioembolization in Treatment of Hepatocellular Carcinoma: A Pictorial Review
Frank H. Miller et al.
RADIOGRAPHICS (2021)
Hepatocellular carcinoma locoregional therapies: Outcomes and future horizons
Mina S. Makary et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2021)
Clinical practice of transarterial chemoembolization for hepatocellular carcinoma: consensus statement from an international expert panel of International Society of Multidisciplinary Interventional Oncology (ISMIO)
Jian Lu et al.
HEPATOBILIARY SURGERY AND NUTRITION (2021)
Atezolizumab plus bevacizumab versus sorafenib or atezolizumab alone for unresectable hepatocellular carcinoma: A systematic review
Faiza Ahmed et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2021)
SBRT for HCC: Overview of technique and treatment response assessment
Kimberly L. Shampain et al.
ABDOMINAL RADIOLOGY (2021)
Prospective Study of Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma on Waitlist for Liver Transplant
Tiffany Cho-Lam Wong et al.
HEPATOLOGY (2021)
Hepatobiliary Cancers, Version 2.2021
Al B. Benson III et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
National Experience on Down-Staging of Hepatocellular Carcinoma Before Liver Transplant: Influence of Tumor Burden, Alpha-Fetoprotein, and Wait Time
Neil Mehta et al.
HEPATOLOGY (2020)
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Sorafenib treatment has the potential to downstage advanced hepatocellular carcinoma before liver resection
Alessandra Bertacco et al.
PERSONALIZED MEDICINE (2020)
Locoregional Therapy Approaches for Hepatocellular Carcinoma: Recent Advances and Management Strategies
Mina S. Makary et al.
CANCERS (2020)
Liver transplantation in hepatocellular carcinoma after tumour downstaging (XXL): a randomised, controlled, phase 2b/3 trial
Vincenzo Mazzaferro et al.
LANCET ONCOLOGY (2020)
Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference
Neil Mehta et al.
TRANSPLANTATION (2020)
Conversion therapy for unresectable hepatocellular carcinoma after lenvatinib Three case reports
Tetsu Tomonari et al.
MEDICINE (2020)
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib The CheckMate 040 Randomized Clinical Trial
Thomas Yau et al.
JAMA ONCOLOGY (2020)
Stereotactic Radiofrequency Ablation of Hepatocellular Carcinoma: a Histopathological Study in Explanted Livers
Reto Bale et al.
HEPATOLOGY (2019)
Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention-to-treat analysis
Robbert J. de Haas et al.
HEPATOLOGY (2018)
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Jorge A. Marrero et al.
HEPATOLOGY (2018)
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial
Masatoshi Kudo et al.
LANCET (2018)
Radiation Segmentectomy: Potential Curative Therapy for Early Hepatocellular Carcinoma
Robert J. Lewandowski et al.
RADIOLOGY (2018)
The role of external beam radiotherapy for hepatocellular carcinoma patients with lymph node metastasis: a meta-analysis of observational studies
Chai Hong Rim et al.
CANCER MANAGEMENT AND RESEARCH (2018)
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2017)
Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis
Gonzalo Sapisochin et al.
JOURNAL OF HEPATOLOGY (2017)
Segmental Yttrium-90 Radioembolization versus Segmental Chemoembolization for Localized Hepatocellular Carcinoma: Results of a Single-Center, Retrospective, Propensity Score-Matched Study
Siddharth A. Padia et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2017)
Transarterial chemoembolization in hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis
Jack P. Silva et al.
HPB (2017)
Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis
Peng Chen et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2017)
Liver-Directed Therapies for Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Bela Kis et al.
CANCER CONTROL (2017)
Radiation-induced liver disease: current understanding and future perspectives
Jieun Kim et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2017)
Reassessing the Boundaries of Liver Transplantation for Hepatocellular Carcinoma: Where Do We Stand With Tumor Down-Staging?
Francis Y. Yao et al.
HEPATOLOGY (2016)
1 Management of Postembolization Syndrome Following Hepatic Transarterial Chemoembolization for Primary or Metastatic Liver Cancer
Helen Blackburn et al.
CANCER NURSING (2016)
Comparison of single-session transarterial chemoembolization combined with microwave ablation or radiofrequency ablation in the treatment of hepatocellular carcinoma: a randomized-controlled study
Elshazly Sheta et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2016)
Lipiodol Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review of Efficacy and Safety Data
Riccardo Lencioni et al.
HEPATOLOGY (2016)
Microwave ablation versus radiofrequency ablation for the treatment of hepatocellular carcinoma: A systematic review and meta-analysis
Antonio Facciorusso et al.
INTERNATIONAL JOURNAL OF HYPERTHERMIA (2016)
Randomized Clinical Trial Comparing Proton Beam Radiation Therapy with Transarterial Chemoembolization for Hepatocellular Carcinoma: Results of an Interim Analysis
David A. Bush et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)
Comparative analysis of current guidelines for the treatment of hepatocellular carcinoma
Francesco Tovoli et al.
HEPATIC ONCOLOGY (2016)
Downstaging of hepatocellular cancer before liver transplant: Long-term outcome compared to tumors within Milan criteria
Francis Y. Yao et al.
HEPATOLOGY (2015)
Downstaging hepatocellular carcinoma: A systematic review and pooled analysis
Neehar D. Parikh et al.
LIVER TRANSPLANTATION (2015)
Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma A Systematic Review and Meta-analysis
Ya Ruth Huo et al.
JAMA ONCOLOGY (2015)
Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future
Hyun Young Woo et al.
CLINICAL AND MOLECULAR HEPATOLOGY (2015)
Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma
Loukia S. Poulou et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Side effects of yttrium-90 radioembolization
Ahsun Riaz et al.
FRONTIERS IN ONCOLOGY (2014)
Increased Quality of Life Among Hepatocellular Carcinoma Patients Treated With Radioembolization, Compared With Chemoembolization
Riad Salem et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Down-Staging of Hepatocellular Carcinoma via External-Beam Radiotherapy With Subsequent Liver Transplantation: A Case Report
Alan Wigg et al.
LIVER TRANSPLANTATION (2013)
Bridging and downstaging treatments for hepatocellular carcinoma in patients on the waiting list for liver transplantation
Maurizio Pompili et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma within UCSF Criteria after Liver Resection
Fei Liu et al.
PLOS ONE (2012)
Mortality and complication rates of percutaneous ablative techniques for the treatment of liver tumors: a systematic review
Luis Calzadilla Bertot et al.
EUROPEAN RADIOLOGY (2011)
Safety and Efficacy of Microwave Ablation of Hepatic Tumors: A Prospective Review of a 5-Year Experience
Robert C. G. Martin et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
Johannes Lammer et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2010)
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
Riccardo Lencioni et al.
SEMINARS IN LIVER DISEASE (2010)
A Comparative Analysis of Transarterial Downstaging for Hepatocellular Carcinoma: Chemoembolization Versus Radioembolization
R. J. Lewandowski et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Incidence of Radiation Pneumonitis After Hepatic Intra-Arterial Radiotherapy With Yttrium-90 Microspheres Assuming Uniform Lung Distribution
Riad Salem et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
High pathological risk of recurrence after surgical resection for hepatocellular carcinoma:: An indication for salvage liver transplantation
M Sala et al.
LIVER TRANSPLANTATION (2004)
Resection prior to liver transplantation for hepatocellular carcinoma
J Beighiti et al.
ANNALS OF SURGERY (2003)
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
JM Llovet et al.
HEPATOLOGY (2003)
Share Paper
